CLAUDINA ASHELMAN: Open Payments
NPI 1811082829 · SARATOGA SPRINGS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,147 in 14 payments from 9 companies in 2025. Trend: 2023 $1,278 · 2024 $1,304 · 2025 $1,147
Food & beverage: $1,147
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 4 | $337 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $245 |
| Madrigal Pharmaceuticals | 1 | $135 |
| UCB, Inc. | 1 | $128 |
| Neurelis, Inc. | 1 | $121 |
| Eisai Inc. | 1 | $83 |
| Otsuka America Pharmaceutical, Inc. | 2 | $56 |
| Braeburn Inc. | 1 | $27 |
| Janssen Pharmaceuticals, Inc | 1 | $15 |
Products named: WaveWriter Alpha Prime 16, REZDIFFRA, Rystiggo, VALTOCO, General - Pain Management, Leqembi, ABILIFY MAINTENA, BRIXADI.
Industry payments across NY — which companies pay providers there.
